Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Leading infectious disease epidemiologist Professor Adam Kucharski presented on opportunities to generate key insights into pandemic pathogens while implementing outbreak control measures, using insights from COVID-19, as part of a new series of pandemic sciences seminars.

Colleagues from across the University of Oxford joined Professor Adam Kucharski this week for a seminar on using routine pandemic control measures to uncover epidemic drivers.

Hosted by PSI, the seminar launched a new monthly series of events in Oxford to explore interdisciplinary research in pandemic sciences.

Non-pharmaceutical interventions, such as contact tracing and regular testing in workplaces, were used widely during the COVID-19 pandemic. 

Although the main purpose of these interventions was generally to reduce transmission, Professor Kucharski illustrated how data generated while implementing these interventions could inform key knowledge gaps in our understanding of SARS-CoV-2 epidemiology, which could in turn, improve the design of control measures. 

Reflecting on estimates that his team generated during the COVID-19 pandemic using data collected from these routine control measures, Professor Kucharski explored case studies from study populations familiar with implementing interventions and generating epidemiological data, such as healthcare workers, through to novel and unexpected settings, such as Premier League football players and international travellers. 

Research from Professor Kucharski and colleagues also examined data from non-healthcare settings, for example workplaces like the English Premier League, SpaceX and the Crick Institute, which provided estimates on reinfection protection from antibodies, as well as detailed insights into the infection kinetics of each new SARS-CoV-2 variant. 

 

Read the full story on the Pandemic Sciences Institute website.

Similar stories

From Responsive to Deep Solidarity: Reframing Global Health Governance in an Interdependent World

A new paper co-authored by Oxford Global Health Co-Director Professor Caesar Atuire and Athanasius Afful from the University of Ghana explores how the concepts of deep solidarity and responsive solidarity can help reframe global health governance and address persistent inequities.

Inside the Medicine Quality Monitoring Globe: tracking medicine quality risks in real time

A new study sets the development and the process powering the Medicine Quality Monitoring Globe, the interactive, online tool that maps real-time medicine quality reports in the media. As of October 2026, the system has captured 2.5 million articles.

Adding rituximab to chemotherapy is a cost-effective treatment for Burkitt lymphoma in Tanzania

New research has found that adding rituximab to chemotherapy could be a cost-effective way to improve survival in children with Burkitt lymphoma in Tanzania.

Building the world's evidence base to tackle drug-resistant tuberculosis

£10 million international research programme launches across India, Kazakhstan, Mozambique, South Africa and Vietnam.

New Climate × Health Seminar Series connects researchers across Oxford

A new Climate × Health seminar series is bringing together researchers from across the University of Oxford to exchange ideas, showcase research and develop collaborations to address challenges at the intersection of health and climate change.

Oxford researchers support international response to Bundibugyo virus disease outbreak

Teams from across the University of Oxford are supporting the international response to the current Bundibugyo virus disease outbreak through interdisciplinary research spanning biomedical, public health and social and behavioural science.

Similar stories

From Responsive to Deep Solidarity: Reframing Global Health Governance in an Interdependent World

A new paper co-authored by Oxford Global Health Co-Director Professor Caesar Atuire and Athanasius Afful from the University of Ghana explores how the concepts of deep solidarity and responsive solidarity can help reframe global health governance and address persistent inequities.

Inside the Medicine Quality Monitoring Globe: tracking medicine quality risks in real time

A new study sets the development and the process powering the Medicine Quality Monitoring Globe, the interactive, online tool that maps real-time medicine quality reports in the media. As of October 2026, the system has captured 2.5 million articles.

Adding rituximab to chemotherapy is a cost-effective treatment for Burkitt lymphoma in Tanzania

New research has found that adding rituximab to chemotherapy could be a cost-effective way to improve survival in children with Burkitt lymphoma in Tanzania.

Building the world's evidence base to tackle drug-resistant tuberculosis

£10 million international research programme launches across India, Kazakhstan, Mozambique, South Africa and Vietnam.

New Climate × Health Seminar Series connects researchers across Oxford

A new Climate × Health seminar series is bringing together researchers from across the University of Oxford to exchange ideas, showcase research and develop collaborations to address challenges at the intersection of health and climate change.

Oxford researchers support international response to Bundibugyo virus disease outbreak

Teams from across the University of Oxford are supporting the international response to the current Bundibugyo virus disease outbreak through interdisciplinary research spanning biomedical, public health and social and behavioural science.